Trial Profile
Aliskiren chronotherapy in patients with non-dipper essential hypertension
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 08 Jul 2011
Price :
$35
*
At a glance
- Drugs Aliskiren (Primary)
- Indications Essential hypertension
- Focus Therapeutic Use
- 08 Jul 2011 New trial record
- 20 Jun 2011 Results presented at the 21st European Meeting on Hypertension.